The former preclinical outcomes on the innovative theranostic UV-A device for personalized corneal cross-linking of keratoconus have been published on the July 2018 issue of Journal of Biophotonics. For the importance, the manuscript had the cover of the journal issue.
The manuscript presents the efficacy of the innovative UV-A device in assessing riboflavin concentration in the cornea and determing treatment efficacy in real time.
Vision Engineering Italy is leader in treating corneal disorders with smart innovative solutions.
